Last reviewed · How we verify
AGN-223575 ophthalmic solution
AGN-223575 ophthalmic solution is a corticosteroid used to treat inflammation in the eye.
AGN-223575 ophthalmic solution is a corticosteroid used to treat inflammation in the eye. Used for Treatment of inflammation in the eye.
At a glance
| Generic name | AGN-223575 ophthalmic solution |
|---|---|
| Sponsor | Allergan |
| Drug class | Corticosteroid |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 2 |
Mechanism of action
AGN-223575 ophthalmic solution works by suppressing the immune system's response to inflammation in the eye, thereby reducing swelling and pain. This is achieved through the inhibition of phospholipase A2, a key enzyme involved in the inflammatory process. By reducing inflammation, AGN-223575 ophthalmic solution helps to promote healing and prevent further damage to the eye.
Approved indications
- Treatment of inflammation in the eye
Common side effects
- Eye irritation
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |